Back

Unveiling the mechanism of BDKRB2-mediated protection against hypertension induced by apatinib: a time-series transcriptomic study

28 August 2026 (15:15 - 15:40)
Organised by: Logo
Congress Presentation Part of: Cardiovascular safety, toxicity, and protection across modern pharmacotherapies Cardiotoxicity of Drugs ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Yalu Sun

Dalian (China)

2 More presentations in this session

Presentation thumbnail
Cardiovascular safety of melatonin: insights from nationwide Danish registries
Doctor D. Christensen (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Cardiovascular safety of bexarotene in mycosis fungoides: a propensity-matched analysis of 2,598 patients
Associate Professor C. Filippatos (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular safety, toxicity, and protection across modern pharmacotherapies

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Session
Biomarkers and vascular mechanisms of hypertension and its organ damage
31 August 2025
thumbnail
Congress Presentation
Mdivi-1 reduces blood pressure in gastric cancer-bearing nude mice by ameliorating apatinib-induced Drp1-mediated excessive mitochondrial fission
31 August 2026
thumbnail
Congress Presentation
Elevated circulating DKK1 is associated with pulmonary vascular remodeling in early-stage non-small cell lung cancer
28 August 2026
thumbnail
Congress Presentation
Distinct blood pressure variability phenotype in VEGF–TKI–induced hypertension: a comparative study across cardio-oncology populations
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources